New! View global litigation for patent families

US3012976A - Specific test composition for occult blood - Google Patents

Specific test composition for occult blood Download PDF

Info

Publication number
US3012976A
US3012976A US85011659A US3012976A US 3012976 A US3012976 A US 3012976A US 85011659 A US85011659 A US 85011659A US 3012976 A US3012976 A US 3012976A
Authority
US
Grant status
Grant
Patent type
Prior art keywords
blood
hydroperoxide
water
test
urine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Inventor
Jr Ernest C Adams
James A Peterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Corp
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/726Devices
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • G01N33/725Haemoglobin using peroxidative activity
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/904Oxidation - reduction indicators

Description

3,012,976 SPEIFITEST COMPOSITKGN FDR QQQULT- BLGOD Ernest C. Adams, in, and James A. Peterson, Elkhart, Ind.,. assignors to Miles Laboratories, Inc, Elkhart, Ind a corporation. of Indiana. No Drawing. Filed Nov. 2, 1959; Ser. No. 850,116 8 Claims. (Ci. 252--403) This invention relates to a composition which has utility in the detection of blood. Particularly the invention relates to compositions which are suitable for use in the qualitative detection and-quantitative estimation of blood in body fluids such as urine, vomitus, gastric contents, cerebral spinal fluids and in feces.

The detection of occult blood in body fluids and feces hasbecome an invaluable aid to the medical practitioner in the correct diagnosis of a great number of disorders. Blood is found in the gastric contents and in vorni-tus in conditions associated with erosion of the mucous mem branes, in ulcers and in carcinomas. In the feces, the regular and frequent occurrence ofoccultblood is suggestive of gastro intestinal cancer, gastric or duodenal ulcers or hemorrhoids. In these conditions, the hemorrhage is often so slight that it is not possible to detect blood by microscopic identifications of the erythrocytes (red blood cells) and a sensitive and specific chemical test for occult blood becomes invaluable. In the urine, blood cells (hematuria) or blood pigment. (hemoglobinuria) is found in typhus, scurvy, purpura, pyemia, nephritis, renal calculi, as the result of a burn. covering a large part of the body, by the action. of various hemolytic toxins, etc.

The prior art has recognized the need for a simple, reliable test for occult blood. U48. Patent No. 2,290,436, issued July 21, 1942, to Kamlet, US. Patent No. 2,799,- 660, issued July 16, 1957 to Nicholls and Fonner and US. Patent No. 2,838,377, issued June 10, 1958 to Fonner (all assigned to the instant assignee) illustrate various test compositions which have been supplied to meet this need.

The instant inventive concept, like those of the prior art, are based on the catalytic activity of the prosthetic groups present in blood. These catalytically active substances identified in hemoglobin belong to the general class of hemoproteins, conjugate proteins all of which have the same prosthetic group, iron protoporphyrin or haem. This prosthetic group has the ability to catalyze the transfer of oxygen. from an oxygen source to an acceptor which in turn becomes oxidized. If the acceptor is a dye percursor, colorless until it becomes oxidized and colored in its oxidized form, then the presence of the catalytic activity is indicated by color formation.

Thus the composition of this invention comprises an indicator or dye precursor plus an oxygen source. In the presence of the hemoglobin of blood, which contains the catalytic prosthetic group, the transfer of oxygen from the oxygen source to the acceptor or dye precursor will occur and the indicator will become oxidized and colored. The presence of color, then, is anindication of the presence of blood, andthe rapidity of color formation and the depth or density of the color, when compared to a set of standards, is a means of the quantitative estimation of, the blood present.

In the diagnostic compositions of. the prior art the oxygen source has uniformly been of an inorganic nature such as the peroxides, perborates or persulfates of the alkali or alkaline earth metals. Representative examples include barium peroxide, strontium peroxide, magnesium peroxide, sodium perbosilicate, sodium perborate and'the like.

3,012,976 Patented Dec. 12, 1961 It has been found in the past that the test compositions ofthe prior art utilizing an inorganic" peroxideas the oxygen source must be very carefully controlled as to sensitivity to avoid the possibility of obtainingfalse positivereactions due to the presence of substances demon,- strating peroxidative activity other thanv the prosthetic groups of hemoglobin of blood. The presence of ingested materials such as vegetable peroxidase in human feces has been found to give a positive reaction with the blood tests of the prior art. Other peroxidativel'y active materials such as lacto-peroxidase from milk and verdo-peroxidase will also give false positive reactions with an overly sensitive prior art bloodtest.

It has now been found, andforms the objectof this invention, that certain organic hydroperoxid'es have a specificity for the prosthetic groups of' the hemoglobin of blood. Concentrations of horseradish peroxidase which give an intense reactionv with orthotolidine as an indicator and an inorganic peroxide give no reaction with orthotolidine and the hydroperoxidesof this invention. Using the organic hydroperoxides it is therefore possible to design a test that is extremely sensitive; for. the: detection of occult blood and yet which will give no: false positive reactions in the presence of vegetable peroxidases.

The instant inventive concept will'be' more clearly explainedby reference to the following illustrative exam. ples.

Example 1 Filter paper sticks preparedby cutting E and D No. 627 filter paper into 1 cm. x 10 cm. strips were impreg nated with 4 N citrate buffer solution (pH 4.8) and dried in an oven. The impregnated portion was overlaid with a chloroform solution containing 0.05 ml. cumene hydroperoxide and 20 mg. o-tol-idine base per ml.- The sticks were then dried a few minutes irran oven:

These sticks reacted with 30 seconds to give a blue color with dilutions of blood in water as high as 1:100,- 000. They were less sensitive in urine, reacting at a dilution of 1:20,000 to give the same color.

The specificity of these sticks can be seen by comparing the reactions with blood and horseradish peroxidase with similar reactions of tablets made with strontium peroxide and also of sticks made with l-hydroxycyclo= hexylhydroperoxide-l, and ethyl hydrogen peroxide. The following table illustrates this.

Minimum con- Minimum concen trati on of centratiou. of. peroxidase in hemoglobin in water giving Water giving reaction, reaction; percent percent Gumenehydroperoxide 0.00015 0.00015 l-hydroxycyclohexylhydroperoxide-l.. 010000015 0.00075 Ethyl hydrogen peroxide 0.0000015 0.0015, Strontium peroxide 0. 0000015 0; 0003 It can be seen that based on the minimum concentrations giving reactions that cumene hydroperoxide has 5' times 3 Example 2 Sticks were prepared using diisopropylbenzene hydroperoxide in place of the cumene hydroperoxide of Example 1.

These sticks also possessed the same specificity for the blood catalyzed reaction as noted for the cumene hydroperoxide sticks. They reacted within 30 seconds to give a blue color with dilutions of blood in water as high as 1:100,000. They were 'less sensitive in urine, reacting at a dilution of 1:20,000.

Example 3 Example 4 A powder was prepared with the following compositions:

o-Tolidine base rnilligrams 100 Tartaric acid do 350 Calcium acetate do 6000 Sodium bicarbonate do 500 D and C Red No. 35 do 10 Cumene hydroperoxide do 180 This was used as a powder and also was compressed into tablets.

These materials were used as follows:

One drop of a urine or-water solution containing blood was placed on a filter paper,the tablet or powder was placed over the spot, and 2 drops of water was added. A blue color developed within 30 seconds with a dilution of 1:100,000 blood in water and with 1:20,000 blood in urine. For detection of occult blood in feces, either a smear of the feces was made on the filter paper, or an emulsion of the faces was treated as the urine. The test would detect 1:2,000 blood in the emulsion and 1:200 in the smear.

Example 5 In this example diisopropylbenzene hydroperoxide was used in place of the cumene hydroperoxide of Example 4 and tablets were prepared.

One drop of a urine or water solution containing blood was placed on a filter paper, the tablet or powder was placed-over the spot, and 2 drops of water was added. A blue color developed Within 30 seconds with a dilution of 1:l00,000 blood in water and with 1:20,000 blood in urine. For detection of occult blood in feces, either a smear of the feces Was made on the filter paper, or an emulsion of the feces was treated as the urine. The test would detect 122,000 blood in the emulsion and 1:200 in the smear.

,Example 6 In this example para-menthane hydroperoxide was used in place of cumene hydroperoxide of Example 4.

. One drop of a urine or water solution containing blood was placed on a filter paper, the tablet was placed over I the spot, and 2 drops of water was added. A blue color 4 Example 7 A powder was prepared with the following composition:

' This material was used as a powder and also was compressed into tablets.

One drop of urine or water solution containing blood was placed on a filter paper, the tablet or powder was placed over the spot, and 2 drops of water was added. A blue color developed within 30 seconds with a dilution of 1:100,000 blood in water and with l:20,000 blood in urine. For detection of occult blood in feces, either a smear of the feces was made on the filter paper, or an emulsion of the feces was treated as the urine. The test would detect 1:2,000 blood in the emulsion and 1:200 in the smear.

Example 8 In this example diisopropylbenzene hydroperoxide was used in place of the cumene hydroperoxide of Example 7.

These tablets were used as follows:

One drop of a urine or water solution containing blood was placed on a filter paper, the tablet was placed over the spot, and 2 drops of water was added. A blue color developed within 30 seconds with a dilution of 1:100,000 blood in water and with 120,000 blood in urine. For detection of occult blood in feces, either a smear of the feces was made on the filter paper, or an emulsion of the feces was treated as the urine. The test would detect 1:2,000 blood in the emulsion and 1:200 in the smear.

Example 9 In this example para-menthane hydroperoxide'was used in place of the cumene hydroperoxide of Example 7.

These tablets were used as follows:

One drop of a urine or water solution containing blood was placed on a filter paper, the tablet was placed over the spot, and 2 drops of water was added. A blue color developed within 30 secondswith a dilution of 1:100,000

. blood in water and with 1:20,000 blood in urine. For

may be prepared in the form of a powder or compressed into tablets. In eitherevent, the dye precursor or indicator material may be selected from that group of indicators which will accept the catalyzed transfer of oxygen from the organic hydroperoxide and thereby become oxidized into their colored form. Such dye precursors include o-tolidine, o-toluidine, p-toluidine, o-phenylenediamine, N,N'-dimethyl-p-phenylenediamine, N,N'-diethyip-phenylenediamine, benzidine, p-anisidine, o-cresol, m-cresol, p-cresol, alphanaphthol, betanaphthol, catechol, guaiacol, pyrogallol, etc. The preferred organic hydroperoxides are those of the isopropylbenzene tertiary hydroperoxide type and include cumene hydroperoxide, diisopropylbenzene and paramenthane hydroperoxide. It has been found that other organic hydroperoxides such as ethyl hydroperoxide, and l-hydroxycyclohexylhydroperoxide-1, do not exhibit this specificity for the prosthetic group of hemoglobin.

In the test compositions of this invention it is essential that there be present a bufier material in order to maintain the pH of that portion of the substance being tested within a pH range suitable for the oxidation of the indicator. Normally this pH range will be from about 4 to 7 but will depend upon the indicator used. Buffering materials such as citrate, tartrate, phosphate, phthalate, acetate and mixtures of these may be used.

In the tablet compositions it has been found advantageous to include excipients such as lactose, starch, flour and the like to facilitate the formation of granules. It has also been found advantageous to include in the tablet formulations a background dye of a water insoluble coloring material. This insoluble pigment or dye should contrast strongly with the positive color of the indicator such as the blue of the orthotolidine. It has been found that, in addition to the D and C Red No. 35, described above, that said compositions may be made with D and C Yellow No. 11 and D and C Orange No. 15.

The tablet compositions of this invention may also include as a buffer an acetate such as calcium, sodium, potassium, lithium acetate and the like and a water soluble solid acid which is stronger than acetic acid so that upon hydrolysis it can react with the aforementioned acetate salt to produce acetic acid. Examples of such acid are citric, fumaric, itaconic, maleic, malic, malonic and mandelic.

To summarize with respect to the tablet embodiment of this invention, the test composition will comprise the following:

Preierred range Constituent (parts by weight) Indicator 50150 Organic hydroperoxid 150-300 Bufler 150300 Excipient 2, 000%, 000 Water insoluble dye -10 With respect to the preferred embodiment, that embodiment wherein the active components are impregnated upon a bibulous carrier such as a filter paper strip the test composition will comprise the following:

Preferred range Constituent (parts by weight) Indicator dye l5-25 Organic hydroperoxide 20-70 Buffer 50- 400 Stabilizer .a 5-10 as a paper strip upon which the active ingredients are impregnated or the active ingredients may be combined with suitable excipients and an acetic acid forming combination.

What is claimed is:

l. A test composition in dry solid form for the detection of blood which comprises an organic hydroperoxide selected from the group consisting of cumene hydroperoxide, diisopropylbenzene hydroperoxide and paramenthane bydroperoxide, an indiactor capable of accepting the catalytic transfer of oxygen from the hydroperoxide by means of the prosthetic group of hemoglobin and becoming oxidized to its colored form, and a buffer maintining the pH of material being tested to one within a range of from 4 to 7.

2. A test composition for the detection of blood which comprises a compression of an organic hydropero-x-ide selected from the group consisting of curnene hydroperoxide, diisopropylbenzene hydroperoxide and paranrem thane hydroperoxide, an indicator capable of accepting the catalytic transfer of oxygen from the hydroperoxide by means of the prosthetic group of hemoglobin and becoming oxidized to its colored form, a buffer maintaining the pH of material being tested to one within a range of from 4 to 7, an excipient and a combination of an acetate salt and a water soluble acid capable of combining with said acetate salt upon hydrolysis to form acetic acid.

3. A test composition in dry solid form for the detection of blood which comprises an organic hydroperoxide selected from the group consisting of cumene hydroperoxide, diisopropylbenzene hydroperoxide and paramenthane hydroperoxide, an indicator selected from the group consisting of the derivatives of aniline which are capable of accepting the catalytic transfer of oxygen from the said hyd-roperoxide by means of the prosthetic group of hemoglobin and thereby becoming oxidized to its colored form, and a buffer for maintaining the pH of the material being tested to one within a range of from 4 to 7.

4. A test composition in accordance with claim 3 wherein said organic hydroperoxide is present in an amount between about 20 and parts by wt., wherein said indicator is present inamounts between about 15 and 25 parts by wt., and wherein said butter is present in amounts between about 50 and 400 parts by wt.

5. A test composition in accordance with claim 3 wherein said organic hydroperoxide is cumene IhYdl'O- peroxide.

6. A test composition in accordance with claim 3 wherein said organic hydroperoxide is diisopropylbenzene hydroperoxide.

7. A test composition in accordance with claim 3 wherein said organic hydroperoxide is para-menthane hydroperoxide.

8. A test composition in accordance with claim 3 wherein said indicator material is orthotolidine.

References Cited in the file of this patent UNITED STATES PATENTS

Claims (1)

  1. 3. A TEST COMPOSITION IN DRY SOLID FORM FOR THE DETECTION OF BLOOD WHICH COMPRISES AN ORGANIC HYDROPEROXIDE SELECTED FROM THE GROUP CONSISTING OF CUMENE HYDROPEROXIDE, DIISOPROPYLBENZENE HYDROPEROXIDE AND PARAMENTHANE HYDROPEROXIDE, AN INDICATOR SELECTED FROM THE GROUP CONSISTING OF THE DERIVATIVES OF ANILINE WHICH ARE CAPABLE OF ACCEPTING THE CATALYTIC TRANSFER OF OXYGEN FROM THE SAID HYDROPEROXIDE BY MEANS OF THE PROSTHETIC GROUP OF HEMOGLOBIN AND THEREBY BECOMING OXIDIZED TO ITS COLORED FORM, AND A BUFFER FOR MAINTAINING THE PH OF THE MATERIAL BEING TESTED TO ONE WITHIN A RANGE OF FROM 4 TO 7.
US3012976A 1959-11-02 1959-11-02 Specific test composition for occult blood Expired - Lifetime US3012976A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US3012976A US3012976A (en) 1959-11-02 1959-11-02 Specific test composition for occult blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3012976A US3012976A (en) 1959-11-02 1959-11-02 Specific test composition for occult blood
GB3661560A GB893318A (en) 1959-11-02 1960-10-25 Stable blood detecting composition

Publications (1)

Publication Number Publication Date
US3012976A true US3012976A (en) 1961-12-12

Family

ID=25307297

Family Applications (1)

Application Number Title Priority Date Filing Date
US3012976A Expired - Lifetime US3012976A (en) 1959-11-02 1959-11-02 Specific test composition for occult blood

Country Status (2)

Country Link
US (1) US3012976A (en)
GB (1) GB893318A (en)

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290117A (en) * 1963-06-24 1966-12-06 Miles Lab Occult blood diagnostic composition with color enhancing agent
US3966414A (en) * 1974-01-16 1976-06-29 Bio-Medical Sciences, Inc. Time temperature indicators
US4071321A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances
US4071318A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances
US4071317A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances and process for preparing same
US4132527A (en) * 1974-01-09 1979-01-02 Shionogi & Co., Ltd. Diagnostic compositions, diagnosing instruments, and methods of manufacturing same
US4148611A (en) * 1978-06-28 1979-04-10 Miles Laboratories, Inc. Test composition, device and method for the detection of peroxidatively active substances
US4175923A (en) * 1978-06-26 1979-11-27 Friend William G Method and apparatus for occult blood testing in the home
US4278439A (en) * 1979-12-17 1981-07-14 Miles Laboratories, Inc. Sensitizers for peroxidative activity tests
EP0058334A1 (en) * 1981-02-12 1982-08-25 Miles Laboratories, Inc. Improved system for the determination of glucose in fluids
US4447542A (en) * 1983-04-04 1984-05-08 Miles Laboratories, Inc. Analytical test composition, device and method for the determination of peroxidatively active substances
US4473079A (en) * 1982-09-13 1984-09-25 Jasper David A Simple, small, self-contained tests for occult blood
US4511533A (en) * 1982-10-07 1985-04-16 Helena Laboratories Corporation Test kit for performing a medical test
US4521520A (en) * 1983-04-07 1985-06-04 Smithkline Diagnostics, Inc. Method for in house occult blood testing
US4526869A (en) * 1980-09-24 1985-07-02 Regents Of The University Of Minnesota Method for quantitatively determining the concentration of hemoglobin in a biological sample
US4582685A (en) * 1982-10-07 1986-04-15 Helena Laboratories Corporation Test kit for performing a medical test
US4647541A (en) * 1982-10-07 1987-03-03 Helena Laboratories Corporation Method for performing an occult blood test
US4676950A (en) * 1984-02-03 1987-06-30 Foster Research Corporation Indicator and test device for detecting occult blood
US4956300A (en) * 1982-01-05 1990-09-11 Helena Laboratories Corporation Aid for determining the presence of occult blood, method of making the aid, and method of using the aid
US5081040A (en) * 1987-06-29 1992-01-14 Helena Laboratories Corporation Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5273888A (en) * 1984-01-16 1993-12-28 Helena Laboratories Corporation Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US5439827A (en) * 1992-11-09 1995-08-08 Kyoto Daiichi Kagaku Co., Ltd. Composition for detecting peroxide active material
US5702913A (en) * 1983-12-21 1997-12-30 Helena Laboratories Corporation Chromgen-reagent test system
US20020136436A1 (en) * 2001-02-23 2002-09-26 Schrier Wayne H. Devices and methods for reading and interpreting guaiac-based occult blood tests
US20090240130A1 (en) * 2008-03-18 2009-09-24 Barnes Sr Albert T Examination Device for Blood Detection
US20100111763A1 (en) * 2008-03-18 2010-05-06 Kahn Laurence H Examination Device for Blood Detection

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673654A (en) * 1985-10-31 1987-06-16 Warner-Lambert Company Composition for determining peroxidase-like activity of hemoglobin
GB9113212D0 (en) * 1991-06-19 1991-08-07 Hypoguard Uk Ltd Reagent mixture
GB0900176D0 (en) 2009-01-08 2009-02-11 Campbell James G Detection system apparatus and method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2773906A (en) * 1953-05-06 1956-12-11 Monsanto Chemicals alpha, alpha-dialkyl-ar-phenylbenzyl hydroperoxides
US2838377A (en) * 1950-03-09 1958-06-10 Miles Lab Blood test

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2838377A (en) * 1950-03-09 1958-06-10 Miles Lab Blood test
US2773906A (en) * 1953-05-06 1956-12-11 Monsanto Chemicals alpha, alpha-dialkyl-ar-phenylbenzyl hydroperoxides

Cited By (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3290117A (en) * 1963-06-24 1966-12-06 Miles Lab Occult blood diagnostic composition with color enhancing agent
US4132527A (en) * 1974-01-09 1979-01-02 Shionogi & Co., Ltd. Diagnostic compositions, diagnosing instruments, and methods of manufacturing same
US3966414A (en) * 1974-01-16 1976-06-29 Bio-Medical Sciences, Inc. Time temperature indicators
US4071321A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances
US4071318A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances
US4071317A (en) * 1977-03-14 1978-01-31 Miles Laboratories, Inc. Test composition and device for determining peroxidatively active substances and process for preparing same
US4175923A (en) * 1978-06-26 1979-11-27 Friend William G Method and apparatus for occult blood testing in the home
US4148611A (en) * 1978-06-28 1979-04-10 Miles Laboratories, Inc. Test composition, device and method for the detection of peroxidatively active substances
US4278439A (en) * 1979-12-17 1981-07-14 Miles Laboratories, Inc. Sensitizers for peroxidative activity tests
US4526869A (en) * 1980-09-24 1985-07-02 Regents Of The University Of Minnesota Method for quantitatively determining the concentration of hemoglobin in a biological sample
EP0058334A1 (en) * 1981-02-12 1982-08-25 Miles Laboratories, Inc. Improved system for the determination of glucose in fluids
US4956300A (en) * 1982-01-05 1990-09-11 Helena Laboratories Corporation Aid for determining the presence of occult blood, method of making the aid, and method of using the aid
US4473079A (en) * 1982-09-13 1984-09-25 Jasper David A Simple, small, self-contained tests for occult blood
US4511533A (en) * 1982-10-07 1985-04-16 Helena Laboratories Corporation Test kit for performing a medical test
US4647541A (en) * 1982-10-07 1987-03-03 Helena Laboratories Corporation Method for performing an occult blood test
US4582685A (en) * 1982-10-07 1986-04-15 Helena Laboratories Corporation Test kit for performing a medical test
US4447542A (en) * 1983-04-04 1984-05-08 Miles Laboratories, Inc. Analytical test composition, device and method for the determination of peroxidatively active substances
US4521520A (en) * 1983-04-07 1985-06-04 Smithkline Diagnostics, Inc. Method for in house occult blood testing
US5702913A (en) * 1983-12-21 1997-12-30 Helena Laboratories Corporation Chromgen-reagent test system
US5273888A (en) * 1984-01-16 1993-12-28 Helena Laboratories Corporation Chemical test kit and method for determining the presence of blood in a specimen and for verifying the effectiveness of the chemicals
US4676950A (en) * 1984-02-03 1987-06-30 Foster Research Corporation Indicator and test device for detecting occult blood
US5081040A (en) * 1987-06-29 1992-01-14 Helena Laboratories Corporation Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes
US5196167A (en) * 1989-04-04 1993-03-23 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5217874A (en) * 1989-04-04 1993-06-08 Helena Laboratories Corporation Fecal occult blood test product with positive and negative controls
US5439827A (en) * 1992-11-09 1995-08-08 Kyoto Daiichi Kagaku Co., Ltd. Composition for detecting peroxide active material
US20020136436A1 (en) * 2001-02-23 2002-09-26 Schrier Wayne H. Devices and methods for reading and interpreting guaiac-based occult blood tests
US6850633B2 (en) 2001-02-23 2005-02-01 Beckman Coulter, Inc. Devices and methods for reading and interpreting guaiac-based occult blood tests
US20090240130A1 (en) * 2008-03-18 2009-09-24 Barnes Sr Albert T Examination Device for Blood Detection
US20100111763A1 (en) * 2008-03-18 2010-05-06 Kahn Laurence H Examination Device for Blood Detection
US7938776B2 (en) 2008-03-18 2011-05-10 Mederistic Solutions, Inc. Examination device for blood detection

Also Published As

Publication number Publication date Type
GB893318A (en) 1962-04-04 application

Similar Documents

Publication Publication Date Title
Prockop et al. A study of urinary and serum lysozyme in patients with renal disease
Ziegler et al. Studies on the electron transport system. XLIII. The isolation of a succinic-coenzyme Q reductase from beef heart mitochondria
Roxon et al. Reduction of tartrazine by a Proteus species isolated from rats
Mengel et al. Studies of paroxysmal nocturnal hemoglobinuria erythrocytes: Increased lysis and lipid peroxide formation by hydrogen peroxide
Hopkins et al. Glutathione peroxidase in human red cells in health and disease
US3406015A (en) Means for detecting the fertile period
Dutton et al. Oxidation-reduction ptoentials of cytochromes in mitochondria
US4333734A (en) Diagnostic device for fecal occult blood and method of use
Rao et al. Indirect assessment of hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver tissue
US4434235A (en) Method and apparatus for detecting nitrite ions in fluids
Ibrahim et al. Oxidative stress and antioxidant status in mouse liver: effects of dietary lipid, vitamin E and iron
Prival et al. Analysis of a method for testing azo dyes for mutagenic activity in Salmonella typhimurium in the presence of flavin mononucleotide and hamster liver S9
Rice-Evans et al. [241 Total antioxidant status in plasma and body fluids
Keilin et al. Coupled oxidation of alcohol
Smith Cytochrome systems in aerobic electron transport
Boveris et al. The cellular production of hydrogen peroxide
Welsch et al. Dietary phenolic compounds: inhibition of Na+-dependent D-glucose uptake in rat intestinal brush border membrane vesicles
US5198365A (en) Fecal sample immunoassay method testing for hemoglobin
Lutwak-Mann Alcohol dehydrogenase of animal tissues
Keilin Cytochrome and respiratory enzymes
US3598704A (en) Diagnostic device for various sugars
Whanger et al. Effects of selenium and vitamin E on blood selenium levels, tissue glutathione peroxidase activities and white muscle disease in sheep fed purified or hay diets
US3791988A (en) Diagnostic test for glucose
Rapkine Sulphydryl groups and enzymic oxido-reduction
SHINDLER et al. Peroxidase from human cervical mucus